Drug intelligence / Profile preview

Attenuat CLA

Development stage
Unknown
Lead developer
Laboratorios Lafedar
Modality
Small Molecules
Administration
Oral
01

Overview

Attenuat CLA is a nutraceutical product developed and marketed by Laboratorios Lafedar, an Argentine pharmaceutical company. The active ingredient is conjugated linoleic acid (CLA), a naturally occurring fatty acid provided in 1000 mg capsules. It is marketed as a dietary supplement with weight loss (adelgazante) and energizing (energizante) properties. CLA is believed to influence body composition by modulating lipid metabolism, specifically by inhibiting fat storage in adipose tissue and promoting fatty acid oxidation in muscle. In the Argentine market, Attenuat CLA is classified and approved as a nutraceutical/dietary supplement rather than a prescription pharmaceutical medication.

Brand names
Attenuat CLA
Other names
Ácido Linoleíco ConjugadoConjugated Linoleic Acid
02

Targets

LPL (Lipoprotein lipase)PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Attenuat CLA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Attenuat CLA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call